JPS636079B2 - - Google Patents
Info
- Publication number
- JPS636079B2 JPS636079B2 JP7454979A JP7454979A JPS636079B2 JP S636079 B2 JPS636079 B2 JP S636079B2 JP 7454979 A JP7454979 A JP 7454979A JP 7454979 A JP7454979 A JP 7454979A JP S636079 B2 JPS636079 B2 JP S636079B2
- Authority
- JP
- Japan
- Prior art keywords
- phosphorylcholine
- general formula
- choline
- reaction
- cdp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229950004354 phosphorylcholine Drugs 0.000 claims description 31
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 claims description 30
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 10
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 10
- 229960001284 citicoline Drugs 0.000 claims description 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 3
- 235000019743 Choline chloride Nutrition 0.000 claims description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 3
- 229960003178 choline chloride Drugs 0.000 claims description 3
- 125000005265 dialkylamine group Chemical group 0.000 claims description 2
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 description 25
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- -1 monosubstituted amides Chemical class 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004816 paper chromatography Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LOUZURPQCYZSJH-UHFFFAOYSA-N 1-chloro-2-dichlorophosphorylethane Chemical compound ClCCP(Cl)(Cl)=O LOUZURPQCYZSJH-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical class CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical class OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ZWIADYZPOWUWEW-XVFCMESISA-N CDP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-XVFCMESISA-N 0.000 description 1
- ZWIADYZPOWUWEW-UHFFFAOYSA-N Cytidine 5'-diphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- JXYZHMPRERWTPM-UHFFFAOYSA-N hydron;morpholine;chloride Chemical compound Cl.C1COCCN1 JXYZHMPRERWTPM-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
本発明はシチジンジリン酸コリン(以下、
CDP−コリンと略す。)を工業的に製造する方法
に関する。Detailed Description of the Invention The present invention provides choline cytidine diphosphate (hereinafter referred to as
Abbreviated as CDP-choline. ).
CDP−コリンは脳外傷時の意識障害および機
能障害の回復に用いられている重要な医薬であ
り、その製造方法も各種知られている。例えば、
(1)シチジン−5′−リン酸(以下、5′−CMPと略
す。)とホスホリルコリンを縮合せしめる方法。
(特公昭35−13024、特公昭46−37594、特公昭46
−18990、等。)(2)5′−CMPの活性化誘導体とホ
スホリルコリンを反応させる方法。(特公昭42−
1384、特公昭46−2101、等。)(3)ホスホリルコリ
ンの活性化誘導体と5′−CMPを反応させる方法。
(特公昭45−4747、特公昭52−16115、等。)(4)シ
チジン−5′−ジリン酸エタノールアミンを経由す
る方法。(特公昭39−6541、特開昭47−11476、
等。)等が知られている。しかしながらこれらの
方法は、高価な試薬の使用、反応、操作、収率の
いずれか、またはその二つ以上の点で不利な点が
あり工業的に必ずしも有利な方法ではない。 CDP-choline is an important drug used for recovery from impaired consciousness and functional impairment caused by brain trauma, and various methods for its production are known. for example,
(1) A method of condensing cytidine-5'-phosphate (hereinafter abbreviated as 5'-CMP) and phosphorylcholine.
(Tokuko Sho 35-13024, Sho 46-37594, Sho 46
−18990, etc. )(2) A method of reacting an activated derivative of 5′-CMP with phosphorylcholine. (Tokuko Showa 42-
1384, Special Publication Showa 46-2101, etc. )(3) A method of reacting an activated derivative of phosphorylcholine with 5'-CMP.
(Special Publication No. 45-4747, No. 52-16115, etc.) (4) Method via cytidine-5'-diphosphate ethanolamine. (Special Publication No. 39-6541, No. 47-11476,
etc. ) etc. are known. However, these methods have disadvantages in the use of expensive reagents, reaction, operation, yield, or both, and are not necessarily industrially advantageous.
本発明者らはかかる従来法の欠点をなくし安価
で、反応、操作が簡単で工業的に有利なCDP−
コリンの製造法を確立する目的で鋭意研究した結
果、取扱い易く、安価でしかも反応性に豊む新規
な一般式〔〕
(式中N(R)2はモルホリノ基、または低級ジア
ルキルアミノ基を示す。)で表わされる中間体:
ホスホリルコリンジアミデート類を見い出した。
従来ホスホリルコリンのアミド類についてはモノ
置換アミド類しか知られていなかつたが、(例え
ば特公昭45−27561、特開昭47−38929、西独特許
公開2359245)これはホスホリルコリン、あるい
はそのハロゲニドの場合も、正に荷電した分子内
の第四級アンモニウム型窒素が、その分子内で塩
を作り易く、リン酸残基の2個の水酸基のうちの
1個しかエステル化やアミド化されない為に合成
が困難であるとされていた。本発明者らは鋭意研
究の結果、文献未記載のホスホリルコリンのジア
ミド類を安価な工業薬品より容易に製造し、かつ
本化合物と、5′−CMPとを溶媒の存在下あるい
は非存在下に、また酸、塩基の存在下あるいは非
存在下に反応せしめることによつて、従来法の欠
点をなくし、短時間でしかも好収率にCDP−コ
リンを得る方法を見い出し、本研究を完成するに
至つた。すなわち本発明によれば、前記一般式
〔〕ホスホリルコリンジアミデート類と5′−
CMPとを反応せしめることにより、CDP−コリ
ンが好収率で得られる。 The present inventors have solved the drawbacks of such conventional methods, and have developed CDP-CDP, which is inexpensive, easy to react and operate, and is industrially advantageous.
As a result of intensive research aimed at establishing a method for producing choline, we discovered a new general formula that is easy to handle, inexpensive, and highly reactive. (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) Intermediate represented by:
Phosphorylcholine diamidates were discovered.
Conventionally, only monosubstituted amides of phosphorylcholine were known (for example, Japanese Patent Publication No. 45-27561, Japanese Patent Publication No. 47-38929, West German Patent Publication No. 2359245). Difficult to synthesize because the positively charged quaternary ammonium nitrogen in the molecule easily forms salts within the molecule, and only one of the two hydroxyl groups in the phosphoric acid residue is esterified or amidated. It was said to be. As a result of intensive research, the present inventors have found that phosphorylcholine diamides, which have not been described in any literature, can be easily produced using inexpensive industrial chemicals, and the present inventors can easily produce diamides of phosphorylcholine, which have not been described in literature, by combining the present compound and 5'-CMP in the presence or absence of a solvent. Furthermore, by conducting the reaction in the presence or absence of acids and bases, we discovered a method to eliminate the drawbacks of conventional methods and obtain CDP-choline in a short period of time and in good yields, leading to the completion of this research. Ivy. That is, according to the present invention, the phosphorylcholine diamidates of the general formula [] and 5'-
By reacting with CMP, CDP-choline can be obtained in good yield.
本発明において用いられる出発原料の1つであ
るホスホリルコリンジアミデート類は後記で詳細
に示す通り、例えばβ−クロロエチルホスホリル
ジアミデート類をトリメチルアミンと反応せしめ
ることにより、容易にかつ好収率で得ることが出
来る。 As shown in detail later, phosphorylcholine diamidates, which are one of the starting materials used in the present invention, can be obtained easily and in good yield by, for example, reacting β-chloroethylphosphoryl diamidates with trimethylamine. You can get it.
本発明に用いられる溶媒としては、反応を阻害
しない溶媒であれば、何でも良く、また特に無水
にする必要はない。望ましくは、ジメチルホルム
アミド、ジメチルアセトアミド、等が有利である
が、無溶媒下でも実施されうる。反応温度として
は、室温から溶媒の沸点まで実施されるが、望ま
しくは、80゜〜140℃が有利である。反応時間は30
分から24時間まで実施されるが、望ましくは、1
〜4時間が有利である。ホスホリルコリンジアミ
デート類は5′−CMPに対し等モル以上使用する
ことができる。 Any solvent may be used in the present invention as long as it does not inhibit the reaction, and there is no particular need to make it anhydrous. Preferably, dimethylformamide, dimethylacetamide, etc. are used, but it can also be carried out without a solvent. The reaction temperature is from room temperature to the boiling point of the solvent, preferably from 80° to 140°C. reaction time is 30
It is carried out from 1 minute to 24 hours, but preferably 1
~4 hours is advantageous. Phosphorylcholine diamidates can be used in an amount equal to or more than 5'-CMP.
反応系に存在せしめる酸としては、トリクロル
酢酸等の有機酸が好ましいが、硫酸、塩化水素等
の無機酸でも良い。酸の使用量は使用するホスホ
リルコリンジアミデートの0.01から1モル量程度
が好ましい。 The acid to be present in the reaction system is preferably an organic acid such as trichloroacetic acid, but may also be an inorganic acid such as sulfuric acid or hydrogen chloride. The amount of acid used is preferably about 0.01 to 1 mole of the phosphorylcholine diamidate used.
反応混合物から目的物を単離するには、常法に
従つて行えば良い。例えば反応後、溶媒を留去す
るかまたは上澄を傾斜して除くか、または溶媒を
加えて沈澱させるかして、得られた残渣を水に溶
解し、アニオン交換樹脂により目的物を吸着せし
め、次いで希ギ酸水溶液で溶離させる。溶離した
CDP−コリン区分を集め、濃縮、乾燥して目的
物のCDP−コリンを得る。 The target product can be isolated from the reaction mixture by a conventional method. For example, after the reaction, the solvent is distilled off, the supernatant is decanted, or a solvent is added to precipitate, the resulting residue is dissolved in water, and the target product is adsorbed by an anion exchange resin. , followed by elution with dilute aqueous formic acid. eluted
The CDP-choline fraction is collected, concentrated and dried to obtain the target product, CDP-choline.
本発明の特徴は非常に活性度の高い前記一般式
〔〕の化合物をCDP−コリンの合成に利用する
点にある。即ち一般式〔〕の化合物は5′−
CMPと反応し一旦下記一般式〔〕、
(式中N(R)2はモルホリノ基、または低級ジア
ルキルアミノ基を示す。)を反応中間体として与
えるが、反応条件下、このものを単離することな
く加水分解を経てほとんど定量的にかつ高純度に
CDP−コリンを得る点にある。更に一般式〔〕
の化合物を利用することにより適当な溶媒(例え
ばジメチルアセトアミド等)を選ぶことにより、
5′−CMPのトリn−ブチルアミン塩をオルトク
ロロフエノール溶媒中ホスホリルコリンモノアミ
デートと反応させる公知例(特公昭45−4747)の
如く5′−CMPを一旦トリn−ブチルアミン塩な
どの有機アミン塩化する必要もなく5′−CMP自
体で反応させることが出来る。また、一般式
〔〕と5′−CMPの反応の反応時間は先に引例の
特公昭45−4747の例示の場合の100℃、18時間に
比べ100℃、3時間ときわめて短かく、かつ反応
後の操作も溶媒を特に留去する必要なく上澄を傾
斜して除くことが出来る等きわめて工業的に優れ
た有利な方法である。 A feature of the present invention is that the compound of the general formula [], which has a very high activity, is utilized for the synthesis of CDP-choline. That is, the compound of general formula [] is 5'-
Once reacted with CMP, the following general formula [], (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group) is provided as a reaction intermediate, but under the reaction conditions, it is hydrolyzed without isolation, almost quantitatively and High purity
The point is to obtain CDP-choline. Furthermore, the general formula []
By selecting an appropriate solvent (e.g. dimethylacetamide, etc.),
5'-CMP is first converted into an organic amine salt such as tri-n-butylamine salt, as in a known example (Japanese Patent Publication No. 45-4747) in which tri-n-butylamine salt of 5'-CMP is reacted with phosphorylcholine monoamidate in an orthochlorophenol solvent. The reaction can be carried out with 5'-CMP itself without the need for further reaction. In addition, the reaction time for the reaction between the general formula [] and 5'-CMP is extremely short at 100°C for 3 hours, compared to 18 hours at 100°C in the case of the example cited in Japanese Patent Publication No. 45-4747. The subsequent operation is also an extremely industrially advantageous method in which the supernatant can be removed by decanting without the need to specifically distill off the solvent.
本発明における一般式〔〕の化合物であるホ
スホリルコリンジアミデート類は以下に述べる三
方法で製造可能であり個々の化合物、反応条件等
により適切な方法を選ぶことが出来るがこれらの
詳細について以下順を追つて説明する。 Phosphorylcholine diamidates, which are compounds of the general formula [] in the present invention, can be produced by the three methods described below, and an appropriate method can be selected depending on the individual compound, reaction conditions, etc. Details of these methods are as follows: I will explain later.
製造法(1)
(式中、N(R)2はモルホリノ基、または低級ジ
アルキルアミノ基を示す。)で示される如く、ク
ロロエチルホスホリルジアミデート類(一般式
〔〕)を経由する。β−クロロエチルホスホリル
ジクロリド(文献例、J.Amer.Chem.Soc.、51、
953(1929))に無水有機溶媒中でモルホリンまた
は低級ジアルキルアミンと反応させることにより
一般式〔〕の化合物を得る。ついで一般式
〔〕の化合物から一般式〔〕への化合物の変
換は、封管中トリメチルアミンと反応させること
により高収率で得られる。反応溶媒としては、反
応を阻害しない溶媒なら何でも良いが例えば、ベ
ンゼン等の芳香族炭化水素類、クロロホルム等の
ハロゲン化水素類、テトラハイドロフラン等のエ
ーテル類、アセトン等のケトン類、アセトニトリ
ル等のニトリル類、ジメチルホルムアミド等のア
ミド類を挙げることが出来るが、有利には、アセ
トニトリル等のニトリル類が望ましい。反応温度
は室温から溶媒の沸点の間で実施されるが、望ま
しくは50゜〜100℃の温度で実施される。反応時間
は、数時間から数日間で実施される。反応生成物
は、反応液を濃縮することにより結晶またはオイ
ルとして得られる。Manufacturing method (1) (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) via chloroethylphosphoryl diamidates (general formula []). β-chloroethylphosphoryl dichloride (Reference example, J.Amer.Chem.Soc., 51 ,
953 (1929)) with morpholine or lower dialkylamine in an anhydrous organic solvent to obtain a compound of general formula []. Then, the compound of general formula [] is converted into general formula [] by reacting it with trimethylamine in a sealed tube in a high yield. Any reaction solvent may be used as long as it does not inhibit the reaction, but examples include aromatic hydrocarbons such as benzene, hydrogen halides such as chloroform, ethers such as tetrahydrofuran, ketones such as acetone, and acetonitrile. Mention may be made of nitriles and amides such as dimethylformamide, but advantageously nitriles such as acetonitrile are preferred. The reaction temperature is between room temperature and the boiling point of the solvent, preferably between 50° and 100°C. Reaction times range from several hours to several days. The reaction product is obtained as crystals or oil by concentrating the reaction solution.
本製造法は一般式〔〕の化合物を容易にかつ
安価に製造せしめる点において工業的にすぐれて
いる。 This production method is industrially superior in that it allows the compound of general formula [] to be produced easily and at low cost.
製造法(2)
(式中、N(R)2はモルホリノ基、および低級ジ
アルキルアミノ基を示す。)
コリンクロリドと公知のクロロホスホリルジア
ミデート(一般式〔〕)(文献例、J.Chem.
Soc.、1958、1963)とを塩基存在下反応させるこ
とにより一般式〔〕で表わされる、ホスホリル
コリンジアミデートクロライド〔〕が得られ
る。反応溶媒としては、極性有機溶媒、例えば、
ジメチルホルムアミド、ジメチルスルホキシド等
を挙げることが出来る。塩基としては、水素化ナ
トリウム等の無機塩基、2・6・−ルチジン、ピ
リジン等の有機塩基が用いられる。反応温度とし
ては、室温から溶媒の沸点の間で実施されるが、
望ましくは、室温から150℃で実施される。反応
時間は、数時間から数日間実施されるが、有利に
は、8時間前後が望ましい。反応生成物は、沈澱
物を濾取し、濾液を減圧濃縮することにより、ホ
スホリルコリンジアミデートクロライドの結晶ま
たはオイルとして得られる。Manufacturing method (2) (In the formula, N(R) 2 represents a morpholino group and a lower dialkylamino group.) Choline chloride and the known chlorophosphoryl diamidate (general formula []) (Reference examples, J.Chem.
Soc., 1958 , 1963) in the presence of a base to obtain phosphorylcholine diamidate chloride [] represented by the general formula []. As the reaction solvent, polar organic solvents such as
Dimethylformamide, dimethylsulfoxide, etc. can be mentioned. As the base, an inorganic base such as sodium hydride, an organic base such as 2,6-lutidine, pyridine, etc. are used. The reaction temperature is between room temperature and the boiling point of the solvent,
Desirably, it is carried out at room temperature to 150°C. The reaction time ranges from several hours to several days, but is preferably around 8 hours. The reaction product is obtained as crystals or oil of phosphorylcholine diamidate chloride by filtering the precipitate and concentrating the filtrate under reduced pressure.
本製造法は一般式〔〕の化合物を収率良く製
造せしめる点においてすぐれた方法である。 This production method is an excellent method in that it allows the compound of general formula [] to be produced with good yield.
製造法(3)
(式中、N(R)2はモルホリノ基、および低級ジ
アルキルアミノ基を示す。)
公知のホスホリルコリンジクロリデート(文献
例、Compt.Rend.、257、183、(1963)、特公昭47
−32970)とモルホリン、または低級アルキルア
ミンを反応させることにより、一般式〔〕で表
わされるホスホリルコリンジアミデートクロライ
ドが得られる。反応溶媒としては、ジメチルホル
ムアミド、ジメチルスルホキシド、アセトニトリ
ル等の極性溶媒が用いられるが、無溶媒でも実施
される。反応温度としては、氷点下から溶媒の沸
点の間で実施されるが、有利には、−5℃から室
温の間が望ましい。反応時間としては、数時間か
ら数日間実施されるが、有利には、数時間が望ま
しい。反応生成物は、沈澱を濾取し、濾液を減圧
濃縮することにより、ホスホリルコリンジアミデ
ートクロライドの結晶または、オイルとして得ら
れる。本製造は一般式〔〕の化合物を短時間に
かつ容易に製造せしめる点ですぐれている。Manufacturing method (3) (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) Known phosphorylcholine dichloridate (Literature example, Compt. Rend., 257 , 183, (1963), Japanese Patent Publication No. 47
-32970) with morpholine or lower alkylamine, phosphorylcholinediamidate chloride represented by the general formula [] is obtained. As the reaction solvent, polar solvents such as dimethylformamide, dimethylsulfoxide, acetonitrile, etc. are used, but the reaction can also be carried out without a solvent. The reaction temperature is carried out between below freezing and the boiling point of the solvent, preferably between -5°C and room temperature. The reaction time ranges from several hours to several days, and advantageously several hours. The reaction product is obtained as crystals or oil of phosphorylcholine diamidate chloride by filtering the precipitate and concentrating the filtrate under reduced pressure. This production is excellent in that it allows the compound of the general formula [] to be produced easily and in a short time.
以下に本発明の実施例を上げ詳細に説明する
が、これらは本発明を限定するものではない。 Examples of the present invention will be described in detail below, but the present invention is not limited to these examples.
実施例 1
ホスホリルコリンジモルホリデートクロライド
(一般式〔〕、N(R)2=モルホリノ基)1.2gと
5′−CMP1gをジメチルアセトアミド4.5mlに懸濁
し100℃、3時間撹拌下反応せしめる。反応後上
澄のジメチルアセトアミドを傾斜して除き、残渣
を水に溶解し、アンモニア水でPH9.5に調整し、
ダイアイオンSA11B(ギ酸型)120mlに吸着せし
め、0.01〜0.03Mギ酸により溶離する。CDP−コ
リンのフラクシヨンを集めて濃縮し、乾燥するこ
とによりCDP−コリン1.44gを得た。なお本化合
物は、ペーパークロマトグラフイー(エタノー
ル、0.5M−酢酸アンモン5:2)高圧濾紙電気
泳動(0.2M−リン酸バツフアーPH7.4、1500V、
2時間)、核磁気共鳴吸収スペクトル(重水中)、
赤外線吸収スペクトル(臭化カリウムデイスク)、
紫外線吸収スペクトル(PH11、PH7.0、PH1.5)で
標品のCDP−コリンと完全に一致した。Example 1 1.2 g of phosphorylcholine dimorpholito chloride (general formula [ ], N(R) 2 = morpholino group)
1 g of 5'-CMP was suspended in 4.5 ml of dimethylacetamide and reacted at 100°C for 3 hours with stirring. After the reaction, the supernatant dimethylacetamide was decanted, the residue was dissolved in water, and the pH was adjusted to 9.5 with aqueous ammonia.
Adsorb to 120 ml of Diaion SA11B (formic acid type) and elute with 0.01-0.03M formic acid. CDP-choline fractions were collected, concentrated, and dried to obtain 1.44 g of CDP-choline. This compound was analyzed by paper chromatography (ethanol, 0.5M ammonium acetate 5:2), high pressure filter paper electrophoresis (0.2M phosphate buffer PH7.4, 1500V,
2 hours), nuclear magnetic resonance absorption spectrum (in heavy water),
Infrared absorption spectrum (potassium bromide disk),
The ultraviolet absorption spectrum (PH11, PH7.0, PH1.5) completely matched that of standard CDP-choline.
実施例 2
ホスホリルコリンジモルホリデートクロライド
1.2gと5′−CMP1.0gを混和し、100℃で撹拌下
4時間加熱反応せしめる。反応後反応混合物を水
に溶解し、実施例1と同様にイオン交換樹脂によ
る精製処理を行い、CDP−コリン分画を集めて
濃縮し、乾燥することにより、CDP−コリンの
純品1.28gを得た。こうして得られたCDP−コリ
ンは実施例1と同様に、標品のCDP−コリンと
比較同定したところ、完全に一致した。Example 2 Phosphorylcholine dimolholitochloride
1.2 g and 1.0 g of 5'-CMP were mixed and reacted by heating at 100°C for 4 hours with stirring. After the reaction, the reaction mixture was dissolved in water, purified using an ion exchange resin in the same manner as in Example 1, and the CDP-choline fraction was collected, concentrated, and dried to obtain 1.28 g of pure CDP-choline. Obtained. The thus obtained CDP-choline was compared and identified with the standard CDP-choline in the same manner as in Example 1, and it was found to be completely identical.
実施例 3
ホスホリルコリンジモルホリデートクロライド
1.2gと5′−CMP1.0gをジメチルアセトアミド4.5
mlに懸濁し、100℃、3時間撹拌下反応せしめる。
反応後上澄のジメチルアセトアミドを傾斜して除
き、残渣を水に溶解し、実施例1と同様にイオン
交換樹脂による精製処理を行い、CDP−コリン
分画を集めて濃縮し、乾燥することにより、
CDP−コリンの純品1.38gを得た。こうして得ら
れたCDP−コリンは実施例1と同様に、標品の
CDP−コリンと比較同定したところ、完全に一
致した。Example 3 Phosphorylcholine dimorpholitochloride
1.2g and 1.0g of 5′-CMP with 4.5g of dimethylacetamide
ml and reacted at 100°C for 3 hours with stirring.
After the reaction, the supernatant dimethylacetamide was decanted, the residue was dissolved in water, and purified using an ion exchange resin in the same manner as in Example 1. The CDP-choline fraction was collected, concentrated, and dried. ,
1.38 g of pure CDP-choline was obtained. The thus obtained CDP-choline was prepared in the same way as in Example 1.
When compared and identified with CDP-choline, they were completely identical.
実施例 4
ホスホリルコリン−N・N′−ジエチルジアミ
デートクロライド(一般式〔〕、R=エチル)
1.98gと5′−CMP0.96gをジメチルアセトアミド
3mlに加え、120℃、3時間撹拌下反応せしめる。
反応後、実施例1と同様に処理して、CDP−コ
リン0.88gを得た。こうして得られたCDP−コリ
ンは実施例1と同様に、標品のCDP−コリンと
比較同定したところ、完全に一致した。Example 4 Phosphorylcholine-N・N'-diethyldiamidate chloride (general formula [], R=ethyl)
1.98 g and 0.96 g of 5'-CMP were added to 3 ml of dimethylacetamide and reacted at 120°C for 3 hours with stirring.
After the reaction, the same treatment as in Example 1 was carried out to obtain 0.88 g of CDP-choline. The thus obtained CDP-choline was compared and identified with the standard CDP-choline in the same manner as in Example 1, and it was found to be completely identical.
実施例 5
β−クロロエチルホスホリルジクロリド10gに
ベンゼン20mlを加え、氷冷下撹拌しながらモルホ
リン17.7gをベンゼン60mlに溶かした溶液を徐々
に滴下する。滴下終了後室温で1時間撹拌し、析
出したモルホリンの塩酸塩を濾取する。濾液を濃
縮乾固し10℃以下で放置すると結晶が析出する。
エーテルで結晶を洗滌し乾燥すると、融点53゜〜
58℃のβ−クロロエチルホスホリルジモルホリデ
ート(一般式〔〕、N(R)2=モルホリノ基)の
白色結晶13.1gが得られた。Example 5 20 ml of benzene is added to 10 g of β-chloroethylphosphoryl dichloride, and a solution of 17.7 g of morpholine dissolved in 60 ml of benzene is gradually added dropwise while stirring under ice cooling. After the addition was completed, the mixture was stirred at room temperature for 1 hour, and the precipitated morpholine hydrochloride was collected by filtration. If the filtrate is concentrated to dryness and left at 10°C or lower, crystals will precipitate.
When the crystals are washed with ether and dried, the melting point is 53° ~
13.1 g of white crystals of β-chloroethylphosphoryl dimorpholinate (general formula [], N(R) 2 =morpholino group) at 58° C. were obtained.
元素分析(C10H20ClN2O4Pとして)
理論値 C:40.21%、H:6.75%、N:9.37%
分析値 C:40.14%、H:6.83%、N:9.38%
次にこのβ−クロロエチルホスホリルジモルホ
リデート5gに、トリメチルアミンの30%アセト
ニトリル溶液20gを加え、封管中70℃で48時間反
応させる。反応後析出物を濾取し、濾液を濃縮
し、少量のジオキサンを加え10℃以下で放置する
と結晶化し、融点64゜〜70℃のホスホリルコリン
ジモルホリデートクロライド(一般式〔〕N
(R)2=モルホリノ基)の白色結晶5.4gが得られ
た。Elemental analysis (as C 10 H 20 ClN 2 O 4 P) Theoretical value C: 40.21%, H: 6.75%, N: 9.37% Analytical value C: 40.14%, H: 6.83%, N: 9.38% Next, this β - Add 20 g of a 30% acetonitrile solution of trimethylamine to 5 g of chloroethylphosphoryl dimorpholidate and react in a sealed tube at 70° C. for 48 hours. After the reaction, the precipitate is collected by filtration, the filtrate is concentrated, a small amount of dioxane is added, and when it is left to stand at below 10°C, it crystallizes to form phosphorylcholine dimorpholidite chloride (general formula []N
5.4 g of white crystals of (R) 2 =morpholino group) were obtained.
元素分析(C13H29ClN3O4P・H2Oとして)
理論値C:41.73%、H:8.36%、N:11.22%
分析値C:41.85%、H:8.41%、N:11.39%
得られたホスホリルコリンジモルホリデートク
ロライドを用い実施例1〜3のとおり実施し同じ
くシチジンジリン酸コリンを得た。Elemental analysis (as C 13 H 29 ClN 3 O 4 P・H 2 O) Theoretical value C: 41.73%, H: 8.36%, N: 11.22% Analytical value C: 41.85%, H: 8.41%, N: 11.39% Using the obtained phosphorylcholine dimorpholithochloride, the same procedure as in Examples 1 to 3 was carried out to obtain choline cytidine diphosphate.
実施例 6
β−クロロエチルホスホロジクロライド10gに
ベンゼン20mlを加え、氷冷下撹拌しながら、ジエ
チルアミン15.6gをベンゼン60mlに溶かした溶液
を滴下する。滴下終了後室温で1時間撹拌し、析
出した沈澱を濾取し、濾液を濃緒する。残渣を減
圧蒸留することにより、沸点108℃(7mmHg)の
無色オイル状のβ−クロロエチルホスホロ−N・
N′−ジエチルジアミデート(一般式〔〕R=
エチル)9.6gが得られた。Example 6 20 ml of benzene is added to 10 g of β-chloroethylphosphorodichloride, and a solution of 15.6 g of diethylamine dissolved in 60 ml of benzene is added dropwise while stirring under ice cooling. After the addition was completed, the mixture was stirred at room temperature for 1 hour, the precipitate was collected by filtration, and the filtrate was concentrated. By distilling the residue under reduced pressure, β-chloroethylphosphoro-N.
N'-diethyldiamidate (general formula []R=
ethyl) was obtained.
次にこのβ−クロロエチルホスホロ−N・
N′−ジエチルジアミデート5gに、トリメチル
アミンの30%アセトニトリル溶液20gを加え、封
管中70℃にて48時間反応せしめる。反応後、反応
液を濃縮し、ジオキサンを加え、不溶物を濾取す
る。濾液を濃縮乾固すると、ホスホリルコリン−
N・N′−ジエチルジアミデートクロライド(一
般式〔〕R=エチル)が3.65g得られた。この
ものはペーパークロマトグラフイーでモノスポツ
トであり(エタノール:0.5M−酢酸アンモン、
10:1、HI試薬で検出、)、ガス、シリカゲル薄
層クロマトグラフイーでもモノスポツトであつた
(クロロホルム:メタノール、1:2、HI試薬、
ヨウ素で検出、)。核磁気共鳴吸収スペクトル、
δ1.17(12H、t、J=7Hz)、δ3.1(8H、m、)、
δ3.27(9H、s)、δ3.72(2H、m)、δ4.35(2H、
m)、〔溶媒メタノール−d4、内部標準TMS、
Varian T−60〕
得られたホスホリルコリン−N・N′−ジエチ
ルジアミデートクロライドを用い実施例4のとお
り実施し同じくシチジンジリン酸コリンを得た。 Next, this β-chloroethylphosphoro-N・
20 g of a 30% acetonitrile solution of trimethylamine was added to 5 g of N'-diethyldiamidate, and the mixture was allowed to react in a sealed tube at 70° C. for 48 hours. After the reaction, the reaction solution is concentrated, dioxane is added, and insoluble matter is filtered off. When the filtrate is concentrated to dryness, phosphorylcholine-
3.65 g of N.N'-diethyldiamidate chloride (general formula []R=ethyl) was obtained. This is a paper chromatography monospot (ethanol: 0.5M - ammonium acetate,
10:1, detected with HI reagent), gas, and silica gel thin layer chromatography (chloroform:methanol, 1:2, HI reagent,
Detected with iodine). nuclear magnetic resonance absorption spectrum,
δ1.17 (12H, t, J=7Hz), δ3.1 (8H, m,),
δ3.27 (9H, s), δ3.72 (2H, m), δ4.35 (2H,
m), [solvent methanol- d4 , internal standard TMS,
Varian T-60] Using the obtained phosphorylcholine-N·N'-diethyldiamidate chloride, the same procedure as in Example 4 was carried out to obtain choline cytidine diphosphate.
実施例 7
コリンクロリド1.4gとクロロホスホリルジモ
ルホリデート2.55gをジメチルスルホキシド5ml
に混和し、撹拌しながら水素化ナトリウム0.24g
を加え、室温で8時間撹拌下反応させる。反応後
析出した少量の沈澱を濾取し、濾液を減圧下濃縮
乾固する。残渣に少量のアセトニトリルを加え、
濾過し、濾液を濃縮し、10℃以下で放置すると、
白色結晶のホスホリルコリンジモルホリデートク
ロライド(一般式〔〕N(R)2=モルホリノ基)
が2.05g得られた。このものは実施例5で得られ
た結晶と融点、ペーパークロマトグラフイー(エ
タノール:0.5M−酢酸アンモン、10:1、HI試
薬で検出)、で完全に一致した。Example 7 1.4 g of choline chloride and 2.55 g of chlorophosphoryl dimorpholidate were mixed with 5 ml of dimethyl sulfoxide.
0.24 g of sodium hydride while stirring.
was added and reacted at room temperature for 8 hours with stirring. After the reaction, a small amount of precipitate is collected by filtration, and the filtrate is concentrated to dryness under reduced pressure. Add a small amount of acetonitrile to the residue,
Filter, concentrate the filtrate, and leave it at below 10°C.
White crystalline phosphorylcholine dimorpholitochloride (general formula []N(R) 2 = morpholino group)
2.05g of was obtained. This product completely matched the crystals obtained in Example 5 in melting point and paper chromatography (ethanol:0.5M ammonium acetate, 10:1, detected with HI reagent).
得られたホスホリルコリンジモルホリデートク
ロライドを用い実施例1〜3のとおり実施し同じ
くシチジンジリン酸コリンを得た。 Using the obtained phosphorylcholine dimorpholithochloride, the same procedure as in Examples 1 to 3 was carried out to obtain choline cytidine diphosphate.
実施例 8
ホスホリルコリンジクロリデート1gをアセト
ニトリル4mlに加え、撹拌下、冷却しながらモル
ホリン1.36gを滴下する。滴下終了後室温で3時
間撹拌し、ベンゼン10mlを加え、室温で更に30分
間撹拌し、析出した白色結晶を濾取する。濾液を
濃縮乾固し、残渣に少量のアセトニトリルを加え
濾過し、濾液を10℃上下で放置すると、白色結晶
のホスホリルコリンジモルホリデートクロライド
0.56gが得られた。この結晶は実施例5で得られ
た結晶と融点、ペーパークロマトグラフイー、核
磁気共鳴吸収スペクトルで完全に一致した。Example 8 1 g of phosphorylcholine dichloridate is added to 4 ml of acetonitrile, and 1.36 g of morpholine is added dropwise while stirring and cooling. After the addition was completed, the mixture was stirred at room temperature for 3 hours, 10 ml of benzene was added, and the mixture was further stirred at room temperature for 30 minutes, and the precipitated white crystals were collected by filtration. The filtrate is concentrated to dryness, a small amount of acetonitrile is added to the residue, it is filtered, and the filtrate is left at 10°C or lower to produce white crystals of phosphorylcholine dimorpholitochloride.
0.56g was obtained. This crystal completely matched the crystal obtained in Example 5 in melting point, paper chromatography, and nuclear magnetic resonance absorption spectrum.
得られたホスホリルコリンジモルホリデートク
ロライドを用い実施例1〜3のとおり実施し同じ
くシチジンジリン酸コリンを得た。 Using the obtained phosphorylcholine dimorpholithochloride, the same procedure as in Examples 1 to 3 was carried out to obtain choline cytidine diphosphate.
Claims (1)
ルキルアミノ基を示す。)で表わされるホスホリ
ルコリンジアミデート類とシチジン−5′−モノリ
ン酸を反応せしめることを特徴とするシチジンジ
リン酸コリンの製造方法。 2 一般式〔〕 (式中N(R)2はモルホリノ基、または低級ジア
ルキルアミノ基を示す。)で表わされるβ−クロ
ロエチルホスホリルジアミデートをトリメチルア
ミンと反応させ一般式〔〕で表わされるホスホ
リルコリンジアミデート類とし、ついでシチジン
−5′−モノリン酸と反応せしめることを特徴とす
るシチジンジリン酸コリンの製造方法。 3 一般式〔〕 (式中N(R)2はモルホリノ基、または低級ジア
ルキルアミノ基を示す。)で表わされるクロロホ
スホリルジアミデート類とコリンクロリドを反応
させ一般式〔〕で表わされるホスホリルコリン
ジアミデート類とし、ついでシチジン−5′−モノ
リン酸と反応せしめることを特徴とするシチジン
ジリン酸コリンの製造方法。 4 ホスホリルコリンジクロリデートとモルホリ
ンまたは低級ジアルキルアミンを反応させ一般式
〔〕で表わされるホスホリルコリンジアミデー
ト類とし、ついでシチジン−5′−モノリン酸と反
応せしめることを特徴とするシチジンジリン酸コ
リンの製造方法。[Claims] 1. General formula [] (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group.) Production of choline cytidine diphosphate, which is characterized by reacting a phosphorylcholine diamidate represented by the formula with cytidine-5'-monophosphoric acid. Method. 2 General formula [] (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group) is reacted with trimethylamine to obtain phosphorylcholine diamidates represented by the general formula []. , and then reacting with cytidine-5'-monophosphoric acid. 3 General formula [] (In the formula, N(R) 2 represents a morpholino group or a lower dialkylamino group) is reacted with choline chloride to obtain phosphorylcholine diamidates represented by the general formula [ ], A method for producing choline cytidine diphosphate, which comprises then reacting it with cytidine-5'-monophosphoric acid. 4. A method for producing choline cytidine diphosphate, which comprises reacting phosphorylcholine dichloridate with morpholine or lower dialkylamine to obtain phosphorylcholine diamidates represented by the general formula [], and then reacting with cytidine-5'-monophosphoric acid. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7454979A JPS55167298A (en) | 1979-06-15 | 1979-06-15 | Preparation of cytidine diphosphate choline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7454979A JPS55167298A (en) | 1979-06-15 | 1979-06-15 | Preparation of cytidine diphosphate choline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55167298A JPS55167298A (en) | 1980-12-26 |
| JPS636079B2 true JPS636079B2 (en) | 1988-02-08 |
Family
ID=13550434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7454979A Granted JPS55167298A (en) | 1979-06-15 | 1979-06-15 | Preparation of cytidine diphosphate choline |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55167298A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282215U (en) * | 1988-12-16 | 1990-06-26 |
-
1979
- 1979-06-15 JP JP7454979A patent/JPS55167298A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282215U (en) * | 1988-12-16 | 1990-06-26 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55167298A (en) | 1980-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0521923B1 (en) | Process for producing nucleosides, and analogs therof | |
| US4567254A (en) | Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
| CA2268586A1 (en) | Process for producing n-glycyltyrosine and its crystal structure | |
| US4751293A (en) | Process for preparation of N6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
| JPS5936914B2 (en) | Cephalosporin analogs | |
| BG62287B1 (en) | Method and intermediate product for oxytetracycline purification | |
| US4371472A (en) | Process for preparing cysteamine-S-substituted compounds and derivatives thereof | |
| JPS6331475B2 (en) | ||
| JPS629598B2 (en) | ||
| CA1297878C (en) | Process for the obtention of the ethyl ester of the apovincaminic acid | |
| HU196385B (en) | Process for producing nizatidine | |
| US5215973A (en) | Optically active and racemic hydrated diacetylesters of α-glycero-phosphoryl-choline | |
| SU667142A3 (en) | Method of producing 1-/l (-)-gamma-amino-alphaoxybutyryl/-kanamycin a | |
| JPH10287657A (en) | Production of radiosensitizer | |
| EP0293244A2 (en) | N epsilon-trifluoroacetyl-L-lysyl-L-proline.D-1O-camphorsulfonic acid salt and process for producing the same | |
| JPH03135995A (en) | Separation and purification of 8-alkoxyadenosine-3',5'-cyclic phosphate | |
| JPS601199A (en) | Preparation of cytidine-5'-diphosphate choline | |
| EP0690848B1 (en) | Piperazinylpyridinyl water clathrates | |
| US5164500A (en) | Oxetanocin G | |
| CA2061643A1 (en) | Optically active and racemic hydrated diacetylesters of .alpha.-glycero-phosphoryl-choline | |
| CA1055925A (en) | N-formylcephalosporin c and a process for preparing the same | |
| CN121591669A (en) | A method for preparing a sinoamine intermediate | |
| KR930007816B1 (en) | Process for preparing cephem compound | |
| JPS633877B2 (en) | ||
| SU802285A1 (en) | Method of preparing 1-beta-d-arabinofuranosyl-5-fluorocytosine |